^
BIOMARKER:
JAK3 mutation
i
Other names: JAK3, Janus Kinase 3, Tyrosine-Protein Kinase JAK3, Leukocyte Janus Kinase, JAK-3, L-JAK, Janus Kinase 3 (A Protein Tyrosine Kinase Leukocyte), JAK3_HUMAN, JAKL, LJAK
Entrez ID:
›
JAK3 mutation
|
NSCLC
|
JAK3 mutation
|
NSCLC
|
nivolumab Resistant: C3 – Early Trials
|
nivolumab Resistant: C3 – Early Trials
|
JAK3 mutation
|
Prolymphocytic Leukemia
|
JAK3 mutation
|
Prolymphocytic Leukemia
|
venetoclax + ruxolitinib Sensitive: C3 – Early Trials
|
venetoclax + ruxolitinib Sensitive: C3 – Early Trials
|
JAK3 mutation
|
T Acute Lymphoblastic Leukemia
|
JAK3 mutation
|
T Acute Lymphoblastic Leukemia
|
tofacitinib Resistant: C4 – Case Studies
|
tofacitinib Resistant: C4 – Case Studies
|
